Physiopathologie des brûlures oculaires

Reim, 1986, Pathogenesis and treatment of caustic burns, Bull Soc Belge Ophtalmol, 213, 41 Brodovsky, 2000, Management of alkali burns: an 11-year retrospective review, Ophthalmology, 107, 1829, 10.1016/S0161-6420(00)00289-X Wagoner, 1997, Chemical injuries of the eye: current concepts in pathophysiology and therapy, Surv Ophthalmol, 41, 275, 10.1016/S0039-6257(96)00007-0 Kuckelkorn, 2002, Emergency treatment of chemical and thermal eye burns, Acta Ophthalmol Scand, 80, 4, 10.1034/j.1600-0420.2002.800102.x Graupner, 1973, Effect of paracentesis on the change in pH in the anterior chamber of rabbit eyes after experimental burning with acid or base, Albrecht Von Graefes Arch Klin Exp Ophthalmol, 186, 67, 10.1007/BF00410080 Stein, 1973, Intraocular pressure response to experimental alkali burns, Am J Ophthalmol, 75, 99, 10.1016/0002-9394(73)90658-2 Paterson, 1974, Intraocular pressure changes after alkali burns, Arch Ophthalmol, 91, 211, 10.1001/archopht.1974.03900060219014 Paterson, 1975, Prostaglandin-like activity in the aqueous humor following alkali burns, Invest Ophthalmol, 14, 177 Awan, 1975, Delayed cataract formation after alkali burn, Can J Ophthalmol, 10, 423 Kuckelkorn, 1995, Poor prognosis of severe chemical and thermal burns. The need for adequate emergency care and primary prevention, Int Arch Occup Environ Health, 67, 281, 10.1007/BF00409410 Conners, 1997, Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium, Invest Ophthalmol Vis Sci, 38, 1963 Schultz, 1992, Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases, Invest Ophthalmol Vis Sci, 33, 3325 Philipp, 2000, Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas, Invest Ophthalmol Vis Sci, 41, 2514 Tanaka, 1998, Aqueous vascular endothelial growth factor increases in anterior segment ischemia in rabbits, Jpn J Ophthalmol, 42, 85, 10.1016/S0021-5155(97)00116-0 Cursiefen, 2000, Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization, Cornea, 19, 526, 10.1097/00003226-200007000-00025 Rieck, 1992, Recombinant human basic fibroblast growth factor (Rh-bFGF) in three different wound models in rabbits: corneal wound healing effect and pharmacology, Exp Eye Res, 54, 987, 10.1016/0014-4835(92)90163-M Ma, 1999, Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells, Invest Ophthalmol Vis Sci, 40, 1822 Hernandez, 2001, Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2, J Exp Med, 193, 607, 10.1084/jem.193.5.607 Stechschulte, 2001, Rapid ocular angiogenic control via naked DNA delivery to cornea., Invest Ophthalmol Vis Sci, 42, 1975 Kim, 2001, Optimal concentration of human epidermal growth factor (hEGF) for epithelial healing in experimental corneal alkali wounds, Curr Eye Res, 22, 272, 10.1076/ceyr.22.4.272.5507 Reim, 1988, Effect of epidermal growth factor in severe experimental alkali burns, Ophthalmic Res, 20, 327, 10.1159/000266738 Chiang, 1971, Ocular hypertensive response following acid and alkali burns in rabbits, Invest Ophthalmol, 10, 270 Diebold, 2001, Presence of nerves and their receptors in mouse and human conjunctival goblet cells, Invest Ophthalmol Vis Sci, 42, 2270 Lambiase, 2000, Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting, Arch Ophthalmol, 118, 1446, 10.1001/archopht.118.10.1446 Lambiase, 2000, Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas, Invest Ophthalmol Vis Sci, 41, 1063 Bonini, 2000, Topical treatment with nerve growth factor for neurotrophic keratitis, Ophthalmology, 107, 1351, 10.1016/S0161-6420(00)00163-9 Gaton, 1999, Matrix metalloproteinase-1 localization in the normal human uveoscleral outflow pathway, Invest Ophthalmol Vis Sci, 40, 363